News_Details

PHEXCOM

Solution BY Communication

>>Back

Merck nabs 'breakthrough' label for anti-melanoma drug

Publisher：
Publication：2013/4/25

Merck ($MRK) won the FDA's "Breakthrough Therapy" tag for its experimental antibody drug lambrolizumab, aimed at advanced melanoma. The designation was based on Phase Ib data that showed significant early signs of antitumor activity in some patients with aggressive cases of the deadly skin cancer.

Excipients

oleaginous vehicle
flavoring agent
viscosity-increasing agent
suspending agent
disintegrant
thickener
solvent
alkalizing agent
chelating agent
emulsifying agent
buffer
adhesive
coating agent
sweetening agent
film-former
gelling agent
solublizing agent
diluent
preservative
carrier